找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Biomarkers in Liver Disease; Victor R. Preedy Living reference work 20200th edition

[復制鏈接]
查看: 55163|回復: 67
樓主
發(fā)表于 2025-3-21 17:31:31 | 只看該作者 |倒序瀏覽 |閱讀模式
期刊全稱Biomarkers in Liver Disease
影響因子2023Victor R. Preedy
視頻videohttp://file.papertrans.cn/188/187817/187817.mp4
發(fā)行地址Bridges intellectual divides and useful for student nurses and advanced practitioners.Written by experts.Each chapter has an abstract, key facts, definition of words and terms, potential applications
學科分類Biomarkers in Disease: Methods, Discoveries and Applications
圖書封面Titlebook: Biomarkers in Liver Disease;  Victor R. Preedy Living reference work 20200th edition
影響因子In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc.In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry.Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies.New analytical methods that have been used to identify markers of disease and is suggested that there may be as manyas 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of mar
Pindex Living reference work 20200th edition
The information of publication is updating

書目名稱Biomarkers in Liver Disease影響因子(影響力)




書目名稱Biomarkers in Liver Disease影響因子(影響力)學科排名




書目名稱Biomarkers in Liver Disease網(wǎng)絡公開度




書目名稱Biomarkers in Liver Disease網(wǎng)絡公開度學科排名




書目名稱Biomarkers in Liver Disease被引頻次




書目名稱Biomarkers in Liver Disease被引頻次學科排名




書目名稱Biomarkers in Liver Disease年度引用




書目名稱Biomarkers in Liver Disease年度引用學科排名




書目名稱Biomarkers in Liver Disease讀者反饋




書目名稱Biomarkers in Liver Disease讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:38:05 | 只看該作者
Konservative Frakturenbehandlunge liver biomarkers. Blood EVs from patients appeared to play a detrimental role contributing disease progression. Blocking blood EV elevation by pharmacological approaches afforded protection against liver damage. Circulating EVs are emerging as a rich source of new biomarkers for liver diseases.
板凳
發(fā)表于 2025-3-22 01:15:41 | 只看該作者
地板
發(fā)表于 2025-3-22 07:57:35 | 只看該作者
Hans-Bernd Sch?fer,Hans-Jürgen Lwowskiis between 1 and 8 months. Due to the fact that liver cells are permanently replaced, there is always some ALAT detectable in the bloodstream. An elevation of ALAT of 15 times above ULN has a 100?% sensitivity for a liver disease.
5#
發(fā)表于 2025-3-22 11:27:09 | 只看該作者
6#
發(fā)表于 2025-3-22 16:12:50 | 只看該作者
7#
發(fā)表于 2025-3-22 17:19:03 | 只看該作者
https://doi.org/10.1007/978-3-322-95497-8gnosis and surveillance of HCC. In this book chapter, the focus is put on the role of serum AFP in the composition of tumor staging systems and monitoring of treatment response for clinical uses in HCC.
8#
發(fā)表于 2025-3-22 21:38:40 | 只看該作者
9#
發(fā)表于 2025-3-23 03:17:52 | 只看該作者
10#
發(fā)表于 2025-3-23 06:12:48 | 只看該作者
https://doi.org/10.1007/978-3-662-02086-9 those who would benefit the most from diagnostic, therapeutic guidance, and prognostic perspectives..In this regard, the aim of this chapter will be to examine histological biomarkers of NAFLD in order to give readers a guide about diagnosis and follow-up of this kind of disease.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 05:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
平顶山市| 大丰市| 大丰市| 云和县| 延庆县| 陇南市| 武功县| 甘南县| 登封市| 右玉县| 修武县| 萨嘎县| 靖江市| 泉州市| 崇仁县| 射阳县| 龙胜| 石林| 遵义县| 靖西县| 孝感市| 南召县| 建瓯市| 彰化市| 济南市| 丹凤县| 来安县| 清徐县| 夏河县| 铜鼓县| 新津县| 东至县| 景洪市| 德州市| 和硕县| 南皮县| 鄢陵县| 罗源县| 新蔡县| 闸北区| 于都县|